Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemia (Q67927103)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Dose-dependent kinetics of orally administered 6-mercaptopurine in children with leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

Y. Kato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

T. Matsushita

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

K. Chiba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

N. Hijiya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

T. Yokoyama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

T. Ishizaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1861221

12 December 2022

language of work or name

English

0 references

publication date

1 August 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:S0022347605807516?httpAccept=text/xml

1 reference

10.1016/S0022-3476(05)80751-6

DOI

https://api.crossref.org/works/10.1016/S0022-3476(05)80751-6

https://api.elsevier.com/content/article/PII:S0022347605807516?httpAccept=text/plain

12 December 2022

1 reference

10.1016/S0022-3476(05)80751-6

DOI

https://api.crossref.org/works/10.1016/S0022-3476(05)80751-6

The Journal of Pediatrics

12 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

311-316

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

Acute lymphoblastic leukemia in childhood.

19 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

The treatment of acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Large interindividual variations in the pharmacokinetics of oral 6-mercaptopurine in maintenance therapy of children with acute leukaemia and non-Hodgkin lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Pharmacokinetic determinants of 6-mercaptopurine myelotoxicity and therapeutic failure in children with acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

6-mercaptopurine plasma levels in children with acute lymphoblastic leukemia: relation to relapse risk and myelotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Dose-dependent elimination of propranolol and its major metabolites in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and Parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Lorcainide; I. Saturable presystemic elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Bioavailability of low-dose vs high-dose 6-mercaptopurine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Quantitation of 6-mercaptopurine in biologic fluids using high-performance liquid chromatography: a selective and novel procedure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Steady-state pharmacokinetics of phenytoin from routinely collected patient data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Michaelis-Menten pharmacokinetics of diphenylhydantoin and application in the pediatric age patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Studies on the xanthine oxidase activity of mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Variability in caffeine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Effect of allopurinol on caffeine disposition in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Methyltransferase pharmacogenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Drug dosage and remission duration in childhood lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

Incidence of apparent Michaelis-Menten kinetic behavior of theophylline and its parameters (Vmax and Km) among asthmatic children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980751-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)80751-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1861221%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference